Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -2.70K%
March 31, 2026 -4.42K%
December 31, 2025 -943.8%
September 30, 2025 -95.02%
June 30, 2025 -37.45%
March 31, 2025 -55.25%
December 31, 2024 -142.9%
September 30, 2024 -17.78%
June 30, 2024 -37.45%
March 31, 2024 -82.27%
December 31, 2023 -30.39%
September 30, 2023 -37.40%
June 30, 2023 -549.4%
March 31, 2023 63.66%
December 31, 2022 73.21%
September 30, 2022 -263.8%
June 30, 2022 -79.59%
March 31, 2022 -975.8%
Date Value
December 31, 2021 -667.3%
September 30, 2021 -2.22K%
June 30, 2021 -2.73K%
March 31, 2021 -2.65K%
December 31, 2020 -1.39K%
September 30, 2020 -900.3%
June 30, 2020 -442.0%
March 31, 2020 -369.5%
December 31, 2019 -370.2%
September 30, 2019 -224.0%
June 30, 2019 -6.75%
March 31, 2019 -158.3%
December 31, 2018 -13.34%
September 30, 2018 -124.2%
June 30, 2018 -417.0%
March 31, 2018 -277.6%
December 31, 2017 -8.74%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 10.23%
Exelixis, Inc. 33.73%
Ionis Pharmaceuticals, Inc. -42.79%
United Therapeutics Corp. 42.51%
PTC Therapeutics, Inc. 23.16%